Cargando…
Expression of SARS‐CoV‐2 entry factors in human oral tissue
The distribution of cells expressing SARS‐CoV‐2 entry factor angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested. The investigation was conducted with normal flesh tissue and paraffin‐embedded specimens. The ACE2 and TMPRSS2 expressi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013449/ https://www.ncbi.nlm.nih.gov/pubmed/33421967 http://dx.doi.org/10.1111/joa.13391 |
_version_ | 1783673490858049536 |
---|---|
author | Sawa, Yoshihiko Ibaragi, Soichiro Okui, Tatsuo Yamashita, Junro Ikebe, Tetsuro Harada, Hiroyuki |
author_facet | Sawa, Yoshihiko Ibaragi, Soichiro Okui, Tatsuo Yamashita, Junro Ikebe, Tetsuro Harada, Hiroyuki |
author_sort | Sawa, Yoshihiko |
collection | PubMed |
description | The distribution of cells expressing SARS‐CoV‐2 entry factor angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested. The investigation was conducted with normal flesh tissue and paraffin‐embedded specimens. The ACE2 and TMPRSS2 expression was detected with all subjects in the normal mucosa of the keratinized stratified squamous epithelia of the tongue and non‐keratinized stratified squamous epithelia of the lip and cheek. It was found that ACE2 is expressed in the cytoplasm and on the cell membrane mainly in the stratum granulosum of the epithelia while the TMPRSS2 is strongly expressed on the cell membrane mainly in the stratum granulosum and stratum spinosum, but not in the stratum basale. Antibodies’ reactions for ACE2 and TMPRSS2 were not observed in the nuclei or keratin layer. The expression of ACE2 and TMPRSS2 in the oral epithelia appears to be general, and the expression was also observed in the mucous and serous acini of the labial glands. The SARS‐CoV‐2 may transiently attach to the oral mucosa and the minor salivary glands which are present under all of the oral mucosa. The oral cavity can be considered an important organ for SARS‐CoV‐2 attachment and may provide a preventive medical avenue to guard against COVID‐19 by preventing saliva from scattering. |
format | Online Article Text |
id | pubmed-8013449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80134492021-04-01 Expression of SARS‐CoV‐2 entry factors in human oral tissue Sawa, Yoshihiko Ibaragi, Soichiro Okui, Tatsuo Yamashita, Junro Ikebe, Tetsuro Harada, Hiroyuki J Anat Original Papers The distribution of cells expressing SARS‐CoV‐2 entry factor angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in human oral tissues were tested. The investigation was conducted with normal flesh tissue and paraffin‐embedded specimens. The ACE2 and TMPRSS2 expression was detected with all subjects in the normal mucosa of the keratinized stratified squamous epithelia of the tongue and non‐keratinized stratified squamous epithelia of the lip and cheek. It was found that ACE2 is expressed in the cytoplasm and on the cell membrane mainly in the stratum granulosum of the epithelia while the TMPRSS2 is strongly expressed on the cell membrane mainly in the stratum granulosum and stratum spinosum, but not in the stratum basale. Antibodies’ reactions for ACE2 and TMPRSS2 were not observed in the nuclei or keratin layer. The expression of ACE2 and TMPRSS2 in the oral epithelia appears to be general, and the expression was also observed in the mucous and serous acini of the labial glands. The SARS‐CoV‐2 may transiently attach to the oral mucosa and the minor salivary glands which are present under all of the oral mucosa. The oral cavity can be considered an important organ for SARS‐CoV‐2 attachment and may provide a preventive medical avenue to guard against COVID‐19 by preventing saliva from scattering. John Wiley and Sons Inc. 2021-01-09 2021-06 /pmc/articles/PMC8013449/ /pubmed/33421967 http://dx.doi.org/10.1111/joa.13391 Text en © 2021 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Papers Sawa, Yoshihiko Ibaragi, Soichiro Okui, Tatsuo Yamashita, Junro Ikebe, Tetsuro Harada, Hiroyuki Expression of SARS‐CoV‐2 entry factors in human oral tissue |
title | Expression of SARS‐CoV‐2 entry factors in human oral tissue |
title_full | Expression of SARS‐CoV‐2 entry factors in human oral tissue |
title_fullStr | Expression of SARS‐CoV‐2 entry factors in human oral tissue |
title_full_unstemmed | Expression of SARS‐CoV‐2 entry factors in human oral tissue |
title_short | Expression of SARS‐CoV‐2 entry factors in human oral tissue |
title_sort | expression of sars‐cov‐2 entry factors in human oral tissue |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013449/ https://www.ncbi.nlm.nih.gov/pubmed/33421967 http://dx.doi.org/10.1111/joa.13391 |
work_keys_str_mv | AT sawayoshihiko expressionofsarscov2entryfactorsinhumanoraltissue AT ibaragisoichiro expressionofsarscov2entryfactorsinhumanoraltissue AT okuitatsuo expressionofsarscov2entryfactorsinhumanoraltissue AT yamashitajunro expressionofsarscov2entryfactorsinhumanoraltissue AT ikebetetsuro expressionofsarscov2entryfactorsinhumanoraltissue AT haradahiroyuki expressionofsarscov2entryfactorsinhumanoraltissue |